No comments yet

Cooley: IPO Leadership Continues

Palo Alto – November 6, 2017 – According to data from IPO Vital Signs and Pitchbook, Cooley is the #1 ranked law firm for VC-backed IPOs across all industries in the first three quarters of 2017. Additionally, Cooley ranks #1 for all technology and life sciences IPOs and #2 for all IPOs across all industries in the same period. Through the first three quarters of 2017, Cooley has advised on 97 completed capital markets transactions, including 22 IPOs.

Cooley most recently advised US tech issuers Roku on its $252 million IPO, MongoDB on its $221 million IPO and Aquantia on its $61 million IPO. Cooley also most recently advised UK life sciences issuer Nightstar Therapeutics on its $86 million IPO, and the underwriters on UK life sciences issuer NuCana’s $114 million IPO, US life science issuer Optinose’s $138 million IPO and US life sciences issuer OrthoPediatrics on its $60 million IPO. This is in addition to a significant number of issuer- and underwriter-side follow-on offerings upon which Cooley has recently advised. These are the latest examples of the firm’s commitment to and leadership in global capital markets.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Post a comment

You must be logged in to post a comment.